PTH and osteoporosis: Intermittent administration of parathyroid hormone (PTH) 1–34 has emerged as a pivotal therapeutic approach for osteoporosis, primarily because of its strong anabolic effects on bone metabolism (Nakamura et al. 2012; Neer et al. 2001).